. Author manuscript; available in PMC: 2020 Nov 15.

Published in final edited form as: Int J Gynecol Cancer. 2019 Jun 2;29(5):904–909. doi: 10.1136/ijgc-2018-000150

Table 2:

Available immunohistochemical and pathologic characteristics by chemotherapy group

Characteristic	Adjuvant Chemotherapy Regimen
Characteristic	GYN (n=12)	GI (n=9)
CK7>/= CK20
Yes	5 (42%)	6 (67%)
No	-	3 (33%)
Unknown	7 (58%)	-
PAX8 positive
Yes	1 (8%)	1 (11%)
No	-	3 (33%)
Unknown	11 (92%)	5 (56%)
Mucin pattern
Intracellular	2 (17%)	2 (22%)
Extracellular	2 (17%)	-
Both	4 (33%)	2 (22%)
Unknown	4 (33%)	5 (56%)
Stromal invasion
Destructive	-	2 (22%)
Expansile	7 (58%)	1 (11%)
Both	1 (8%)	1 (11%)
Unknown	4 (33%)	5 (56%)